Cargando…

Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder

OBJECTIVE: Residual cognitive symptoms after depression are common and associated with reduced daily life functioning and an increased risk of depression relapse. There is a lack of knowledge on treatments targeting residual cognitive symptoms after major depressive disorder (MDD), including the fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Myklebost, Sunniva Brurok, Gjestad, Rolf, Inal, Yavuz, Hammar, Åsa, Nordgreen, Tine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995427/
https://www.ncbi.nlm.nih.gov/pubmed/35418884
http://dx.doi.org/10.3389/fpsyt.2022.795698
_version_ 1784684293886312448
author Myklebost, Sunniva Brurok
Gjestad, Rolf
Inal, Yavuz
Hammar, Åsa
Nordgreen, Tine
author_facet Myklebost, Sunniva Brurok
Gjestad, Rolf
Inal, Yavuz
Hammar, Åsa
Nordgreen, Tine
author_sort Myklebost, Sunniva Brurok
collection PubMed
description OBJECTIVE: Residual cognitive symptoms after depression are common and associated with reduced daily life functioning and an increased risk of depression relapse. There is a lack of knowledge on treatments targeting residual cognitive symptoms after major depressive disorder (MDD), including the factors associated with treatment response. The aim of the current study is to explore factors of treatment response to a guided internet-delivered intervention for former depressed adults experiencing residual cognitive symptoms. METHOD: Forty-three former depressed adults with residual cognitive symptoms were included. Linear mixed model analyses were used to investigate the impact of pre-treatment demographic-, illness, and symptom variables, and therapy process variables, such as credibility, expectancy, and user behavior, on reduction in residual cognitive symptoms from pre-treatment to 6-month follow-up. RESULTS: Having had MDD for a year or less predicted more reductions in residual cognitive symptoms from pre- to 6-month follow-up. Higher levels of perceived treatment credibility and expectancy evaluated in the early course of treatment did also predict a positive treatment response. No demographic-, symptom-variables, previous number of episodes with MDD, and user behavior were associated with change in residual cognitive symptoms. CONCLUSION: This study suggests that individuals with shorter duration of previous depressions might have larger reductions in residual cognitive symptoms at 6-month follow-up compared to those with a longer duration of depression. Treatment credibility and expectancy also predicted treatment response and effort should also be made to ensure interventions credibility. Results should be interpreted with caution due to the study having a low sample size. Further investigation of predictors should be conducted in a full scale randomized controlled trial.
format Online
Article
Text
id pubmed-8995427
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89954272022-04-12 Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder Myklebost, Sunniva Brurok Gjestad, Rolf Inal, Yavuz Hammar, Åsa Nordgreen, Tine Front Psychiatry Psychiatry OBJECTIVE: Residual cognitive symptoms after depression are common and associated with reduced daily life functioning and an increased risk of depression relapse. There is a lack of knowledge on treatments targeting residual cognitive symptoms after major depressive disorder (MDD), including the factors associated with treatment response. The aim of the current study is to explore factors of treatment response to a guided internet-delivered intervention for former depressed adults experiencing residual cognitive symptoms. METHOD: Forty-three former depressed adults with residual cognitive symptoms were included. Linear mixed model analyses were used to investigate the impact of pre-treatment demographic-, illness, and symptom variables, and therapy process variables, such as credibility, expectancy, and user behavior, on reduction in residual cognitive symptoms from pre-treatment to 6-month follow-up. RESULTS: Having had MDD for a year or less predicted more reductions in residual cognitive symptoms from pre- to 6-month follow-up. Higher levels of perceived treatment credibility and expectancy evaluated in the early course of treatment did also predict a positive treatment response. No demographic-, symptom-variables, previous number of episodes with MDD, and user behavior were associated with change in residual cognitive symptoms. CONCLUSION: This study suggests that individuals with shorter duration of previous depressions might have larger reductions in residual cognitive symptoms at 6-month follow-up compared to those with a longer duration of depression. Treatment credibility and expectancy also predicted treatment response and effort should also be made to ensure interventions credibility. Results should be interpreted with caution due to the study having a low sample size. Further investigation of predictors should be conducted in a full scale randomized controlled trial. Frontiers Media S.A. 2022-03-28 /pmc/articles/PMC8995427/ /pubmed/35418884 http://dx.doi.org/10.3389/fpsyt.2022.795698 Text en Copyright © 2022 Myklebost, Gjestad, Inal, Hammar and Nordgreen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Myklebost, Sunniva Brurok
Gjestad, Rolf
Inal, Yavuz
Hammar, Åsa
Nordgreen, Tine
Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
title Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
title_full Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
title_fullStr Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
title_full_unstemmed Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
title_short Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
title_sort predictors of treatment response to an internet-delivered intervention targeting residual cognitive symptoms after major depressive disorder
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995427/
https://www.ncbi.nlm.nih.gov/pubmed/35418884
http://dx.doi.org/10.3389/fpsyt.2022.795698
work_keys_str_mv AT myklebostsunnivabrurok predictorsoftreatmentresponsetoaninternetdeliveredinterventiontargetingresidualcognitivesymptomsaftermajordepressivedisorder
AT gjestadrolf predictorsoftreatmentresponsetoaninternetdeliveredinterventiontargetingresidualcognitivesymptomsaftermajordepressivedisorder
AT inalyavuz predictorsoftreatmentresponsetoaninternetdeliveredinterventiontargetingresidualcognitivesymptomsaftermajordepressivedisorder
AT hammarasa predictorsoftreatmentresponsetoaninternetdeliveredinterventiontargetingresidualcognitivesymptomsaftermajordepressivedisorder
AT nordgreentine predictorsoftreatmentresponsetoaninternetdeliveredinterventiontargetingresidualcognitivesymptomsaftermajordepressivedisorder